Biocept, Inc. (NASDAQ:BIOC – Get Rating) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 62,100 shares, an increase of 696.2% from the May 15th total of 7,800 shares. Based on an average daily volume of 148,900 shares, the short-interest ratio is presently […]
Biocept, Inc. , a leading provider of molecular diagnostic assays, products and service, announces that management will present at the Maxim Group Virtual Healthcare Conference hosted by M-Vest on. | June 14, 2023
StockNews.com started coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a report released on Wednesday. The firm issued a hold rating on the medical research company’s stock. Separately, Maxim Group downgraded shares of Biocept from a buy rating to a hold rating in a research note on Friday, April 14th. Biocept Price Performance […]